"The situation has shone a light on the severe global inequity that exists when it comes to vaccines and public health crises, and the extent to which profitability is often the key determining factor as to whether vaccines are produced and procured."
"Nobody's going to get rich selling vaccines to Africa," he told DW, emphasizing that companies may only profit from vaccines if the virus affects wealthy nations.
"At the time of writing, the country still does not have any doses of an mpox vaccine, although Japan and the US have pledged to donate vaccines before the end of the month."
"The only vaccine that has secured widespread regulatory approval against mpox is the MVA-BN vaccine produced by Bavarian Nordic, which is marketed under the brand names Jynneos, Imvamune and Imvanex."
Collection
[
|
...
]